Capitalizing on its intellectual resources to spearhead the biomedical research industry, the Asia Pacific market for miRNA is expected to grow to US$ 58 Million by 2018. Most of the ongoing studies in Asia Pacific are based on various types of cancer, with main focus on Colorectal Cancer followed closely by Thyroid, Renal, Breast and Lung Cancer. Other major areas of interest in Asia Pacific include Heart diseases, depression, Alzheimer's, Hepatitis and Sepsis. Most of these are diagnostic in nature, and are focused on evaluation of miRNA expression in various types of cancers.